Frontlight ResearchEarly access
Trial site
Tesshokai Kameda General Hospital
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Amgen1 trial
- Daiichi Sankyo1 trial
Running trials
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026